OK! Here I go. I have been involved in PPHM since the late 80's, yes that long ago. Many on the board know me. I am convinced that the science will make everyone very happy in their investment, and I'm still very positive as a whole. Having said that, there was one little throw away line in the transcript that gives me pause. Hence, this venting . The line is( I paraphrase) " with the Sunrise enrollment now over 90% , it allows us to shift focus to other trials".
That's what has been happening for damn near 30 years. First it was Cotara for GBMF brain cancer. I thought it would be the salvation for my uncle. He's dead. Cotara is no where to be founding part because protocols changed, but mostly because they had a new toy with what is now Bavituximab. I thought that would help my Mother-in-law with her breast cancer. She is dead. Now it appears that Sunrise focus and intensity of development is going to be diluted because we are 90% there.
WE ARE ALWAYS 90% THERE! The science will prove to be right or wrong, but we will never know until we bring something to conclusion. Right now I feel like I'm funding some scientists with A.D.D. Damn it! Finish something! Then you've earned the right to move on to something else. That's the business side of this company that people complain about. We would not have this stock price if something had been completed along the way . There is always a new toy for scientists, always a new frontier to be explored. PPHM is not an open funded exploration tool for scientists to get excited about new "inventions".
We are always in the red zone. Now we're at the 5 yard line. PLEASE GET SOMETHING INTO THE ENDZONE! Sorry for the rant but after this many years, I've earned the right.
